| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 28.0 | 33.2 | 23.8 |
| Other income | 0.2 | 0.1 | 0.0 |
| Total income | 28.1 | 33.3 | 23.8 |
| Profit before exceptional items & tax | 1.2 | 1.5 | 1.3 |
| Exceptional items | 0.0 | 0.1 | 0.0 |
| Profit before tax | 1.2 | 1.6 | 1.3 |
| Net profit | 1.1 | 1.3 | 1.0 |
| Operating margin | 4.3% | 4.8% | 5.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +10.00% |
|---|---|
| Net profit, quarter on quarter | -15.40% |
| Revenue, year on year | +17.60% |
| Operating profit, year on year | -23.10% |
| Operating profit, quarter on quarter | -28.60% |
Source
Read the filing ↗
BSE results filing, NSE: GODAVARI. Figures extracted from the filing.
Godavari Drugs Ltd: key numbers
- Share price
- ₹125.18
- Market cap
- ₹126.8 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹4.09 Cr
- P/E (TTM)
- 30.5×Sector 50.4×
- Promoter holding
- 40.23%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Drugs Ltd
All →
16:43 IST
BSE
Annual General Meeting
Godavari Drugs Annual General Meeting
Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.
16:48 IST
BSE
Financial Results
Godavari Drugs Q4 FY26 Results: Net Profit ₹1.3 Cr, Up 44.4% YoY
Godavari Drugs Ltd reported revenue from operations of ₹33.2 Cr (+30.2% YoY) and net profit of ₹1.3 Cr (+44.4% YoY) for Q4 FY26.
- Key figure
- Net profit ₹1.3 Cr · +44.4% YoY